Armita Abdollahi Govar1, Gábor Törő1, Peter Szaniszlo2, Athanasia Pavlidou3, Sofia-Iris Bibli4, Ketan Thanki5, Vicente A Resto2, Celia Chao5, Mark R Hellmich5, Csaba Szabo1,6, Andreas Papapetropoulos3,7, Katalin Módis1,5. 1. Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas, USA. 2. Department of Otolaryngology, University of Texas Medical Branch, Galveston, Texas, USA. 3. Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece. 4. Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt, Germany. 5. Department of Surgery, University of Texas Medical Branch, Galveston, Texas, USA. 6. Chair of Pharmacology, Department of Science and Medicine, University of Fribourg, Fribourg, Switzerland. 7. Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Abstract
BACKGROUND AND PURPOSE: During angiogenesis, quiescent endothelial cells (ECs) are activated by various stimuli to form new blood vessels from pre-existing ones in physiological and pathological conditions. Many research groups have shown that hydrogen sulfide (H2 S), the newest member of the gasotransmitter family, acts as a proangiogenic factor. To date, very little is known about the regulatory role of 3-mercaptopyruvate sulfurtransferase (3-MST), an important H2 S-producing enzyme in ECs. The aim of our study was to explore the potential role of 3-MST in human EC bioenergetics, metabolism, and angiogenesis. EXPERIMENTAL APPROACH: To assess in vitro angiogenic responses, we used EA.hy926 human vascular ECs subjected to shRNA-mediated 3-MST attenuation and pharmacological inhibition of proliferation, migration, and tube-like network formation. To evaluate bioenergetic parameters, cell respiration, glycolysis, glucose uptake, and mitochondrial/glycolytic ATP production were measured. Finally, global metabolomic profiling was performed to determine the level of 669 metabolic compounds. KEY RESULTS: 3-MST-attenuated ECs subjected to shRNA or pharmacological inhibition of 3-MST significantly reduced EC proliferation, migration, and tube-like network formation. 3-MST silencing also suppressed VEGF-induced EC migration. From bioenergetic and metabolic standpoints, 3-MST attenuation decreased mitochondrial respiration and mitochondrial ATP production, increased glucose uptake, and perturbed the entire EC metabolome. CONCLUSION AND IMPLICATIONS: 3-MST regulates bioenergetics and morphological angiogenic functions in human ECs. The data presented in the current report support the view that 3-MST pathway may be a potential candidate for therapeutic modulation of angiogenesis. LINKED ARTICLES: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc.
BACKGROUND AND PURPOSE: During angiogenesis, quiescent endothelial cells (ECs) are activated by various stimuli to form new blood vessels from pre-existing ones in physiological and pathological conditions. Many research groups have shown that hydrogen sulfide (H2 S), the newest member of the gasotransmitter family, acts as a proangiogenic factor. To date, very little is known about the regulatory role of 3-mercaptopyruvate sulfurtransferase (3-MST), an important H2 S-producing enzyme in ECs. The aim of our study was to explore the potential role of 3-MST in human EC bioenergetics, metabolism, and angiogenesis. EXPERIMENTAL APPROACH: To assess in vitro angiogenic responses, we used EA.hy926 human vascular ECs subjected to shRNA-mediated 3-MST attenuation and pharmacological inhibition of proliferation, migration, and tube-like network formation. To evaluate bioenergetic parameters, cell respiration, glycolysis, glucose uptake, and mitochondrial/glycolytic ATP production were measured. Finally, global metabolomic profiling was performed to determine the level of 669 metabolic compounds. KEY RESULTS: 3-MST-attenuated ECs subjected to shRNA or pharmacological inhibition of 3-MST significantly reduced EC proliferation, migration, and tube-like network formation. 3-MST silencing also suppressed VEGF-induced EC migration. From bioenergetic and metabolic standpoints, 3-MST attenuation decreased mitochondrial respiration and mitochondrial ATP production, increased glucose uptake, and perturbed the entire EC metabolome. CONCLUSION AND IMPLICATIONS: 3-MST regulates bioenergetics and morphological angiogenic functions in human ECs. The data presented in the current report support the view that 3-MST pathway may be a potential candidate for therapeutic modulation of angiogenesis. LINKED ARTICLES: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc.
Authors: Virendra K Chaudhri; Gregory G Salzler; Salihah A Dick; Melanie S Buckman; Raffaella Sordella; Edward D Karoly; Robert Mohney; Brendon M Stiles; Olivier Elemento; Nasser K Altorki; Timothy E McGraw Journal: Mol Cancer Res Date: 2013-03-08 Impact factor: 5.852
Authors: Shyamal C Bir; Gopi K Kolluru; Paul McCarthy; Xinggui Shen; Sibile Pardue; Christopher B Pattillo; Christopher G Kevil Journal: J Am Heart Assoc Date: 2012-10-25 Impact factor: 5.501
Authors: W Samuel Fagg; Naiyou Liu; Ulrich Braunschweig; Karen Larissa Pereira de Castro; Xiaoting Chen; Frederick S Ditmars; Steven G Widen; John Paul Donohue; Katalin Modis; William K Russell; Jeffrey H Fair; Matthew T Weirauch; Benjamin J Blencowe; Mariano A Garcia-Blanco Journal: Nucleic Acids Res Date: 2022-05-20 Impact factor: 19.160